GlassScriptPhysician profile
Steven B Collins
NPI 1033150008
$3,242.38
in general payments reported to CMS, 2019-2025
20 companies · $1,123 in 2025
The $1,123 reported for 2025 was more than what 82% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $408 · 2022: $442 · 2023: $470 · 2024: $800 · 2025: $1,123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,392.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $782.02 | 2022-2025 | Prolate, Nalocet, Tanlor |
| Scilex Pharmaceuticals INC. | $629.28 | 2021-2025 | Ztlido |
| Collegium Pharmaceutical, INC. | $477.98 | 2023-2025 | Belbuca, Xtampza |
| Nevro Corp. | $342.01 | 2021-2022 | |
| Vertos Medical, INC. | $193.07 | 2022-2023 | Mild Device Kit |
| Vertex Pharmaceuticals Incorporated | $157.64 | 2024-2025 | |
| Abbott Laboratories | $109.40 | 2021-2025 | Eterna, Proclaim |
| Si-Bone, INC. | $101.83 | 2022-2025 | |
| Medtronic, INC. | $89.85 | 2025 | Inceptiv |
| Arbor Pharmaceuticals, INC. | $71.92 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $66.78 | 2021 | |
| Biotronik Nro, INC. | $66.67 | 2023 | Biotronik |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.89 | 2021-2022 | |
| Redhill Biopharma INC. | $30.77 | 2022 | |
| Hikma Pharmaceuticals USA | $18.63 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $18.14 | 2023 | Horizant |
| Nalu Medical, INC. | $15.32 | 2023 | Nalu Neurostimulation System |
| Idorsia Pharmaceuticals US INC | $15.03 | 2024 | Quviviq |
| Boston Scientific Corporation | $14.56 | 2022 | |
| Stimwave Technologies Incorporated | $8.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.